Enter cluster sum scores. Each cluster is sum of item ratings (0-4 per item).
Guía detallada próximamente
Estamos preparando una guía educativa completa para el PCL-5 PTSD Score Calculator. Vuelve pronto para ver explicaciones paso a paso, fórmulas, ejemplos prácticos y consejos de expertos.
The PCL-5 (PTSD Checklist for DSM-5) Score Calculator computes a total severity score from 20 items rated 0 to 4, serving as the most widely used self-report screening instrument for post-traumatic stress disorder in both clinical and research settings. Developed by the National Center for PTSD, the PCL-5 maps directly onto the 20 DSM-5 PTSD symptoms across four clusters: intrusion (Cluster B, items 1-5), avoidance (Cluster C, items 6-7), negative alterations in cognitions and mood (Cluster D, items 8-14), and alterations in arousal and reactivity (Cluster E, items 15-20). The total score ranges from 0 to 80, with a provisional diagnostic cutoff of 31 to 33 for probable PTSD diagnosis. This cutoff was established through validation studies comparing PCL-5 scores against the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), the gold standard diagnostic interview. At a cutoff of 33, the PCL-5 demonstrates sensitivity of 0.88 and specificity of 0.69 in veteran populations, and sensitivity of 0.93 with specificity of 0.59 in civilian trauma populations. The PCL-5 replaced the PCL-C, PCL-M, and PCL-S (specific to military, civilian, and stressor-specific contexts) with a single unified instrument aligned to the DSM-5 diagnostic criteria. It can be administered as a self-report questionnaire (taking 5 to 10 minutes) or read aloud by a clinician. The instrument is freely available from the National Center for PTSD with no licensing fees, making it accessible for clinical practice, research, and community screening programs. This calculator is used by VA and military clinicians screening service members and veterans, trauma therapists monitoring treatment progress, emergency department staff screening trauma survivors, researchers measuring PTSD prevalence, and forensic psychologists documenting PTSD symptoms in legal proceedings.
PCL-5 Total Score = Sum of items 1 through 20, each rated 0 (Not at all) to 4 (Extremely). Range: 0-80. Cluster B (Intrusion) = Items 1-5 (range 0-20). Cluster C (Avoidance) = Items 6-7 (range 0-8). Cluster D (Cognition/Mood) = Items 8-14 (range 0-28). Cluster E (Arousal) = Items 15-20 (range 0-24). Provisional PTSD: Total score >= 31-33. DSM-5 symptom criteria method: at least 1 B item + 1 C item + 2 D items + 2 E items rated >= 2 (Moderately). Worked example: Patient rates 20 items with scores summing to 42. Cluster B: 12, C: 5, D: 15, E: 10. Total 42 exceeds cutoff of 33. At least 1B (3/5 >= 2), 1C (2/2 >= 2), 2D (4/7 >= 2), 2E (3/6 >= 2) rated >= 2. Both total score and symptom criteria methods indicate probable PTSD.
- 1The clinician or patient completes the 20-item questionnaire, rating each symptom based on how much it has bothered them in the past month. The response scale is: 0 = Not at all, 1 = A little bit, 2 = Moderately, 3 = Quite a bit, 4 = Extremely. Items reference a specific traumatic event (identified beforehand using the Life Events Checklist for DSM-5, or LEC-5) or the worst traumatic experience if multiple traumas are reported.
- 2Enter each of the 20 item scores into the calculator. The items correspond to specific DSM-5 PTSD symptoms: items 1-5 assess intrusive memories, nightmares, flashbacks, emotional distress to reminders, and physical reactions to reminders. Items 6-7 assess avoidance of trauma-related thoughts and situations. Items 8-14 assess negative beliefs, blame, negative emotions, loss of interest, detachment, and emotional numbing. Items 15-20 assess irritability, reckless behavior, hypervigilance, startle response, concentration difficulties, and sleep disturbance.
- 3The calculator computes the total severity score (0-80) and compares it against the provisional diagnostic cutoff. For general clinical use, a cutoff of 33 is recommended. For VA and military populations, a cutoff of 31 may be more appropriate based on validation studies specific to this population. For primary care screening where sensitivity is prioritized, a cutoff of 28 may be used to minimize missed cases.
- 4Cluster scores are computed separately to identify the symptom profile. Some patients may have elevated Cluster B and E scores (intrusion and hyperarousal-dominant) while others may score higher on Cluster D (negative cognitions and mood). This profile information guides treatment planning: intrusion-dominant presentations may respond better to cognitive processing therapy (CPT) or prolonged exposure (PE), while mood-dominant presentations may benefit from CPT combined with behavioral activation.
- 5The calculator applies the DSM-5 diagnostic algorithm as an alternative scoring method. A provisional PTSD diagnosis requires: at least 1 Cluster B symptom rated >= 2, at least 1 Cluster C symptom rated >= 2, at least 2 Cluster D symptoms rated >= 2, and at least 2 Cluster E symptoms rated >= 2. This method has higher specificity than the total score cutoff and is more closely aligned with the diagnostic criteria.
- 6For treatment monitoring, the calculator compares the current score to previous administrations and computes the change score. A 5-point decrease is considered reliable change (exceeding measurement error), and a 10 to 20-point decrease indicates clinically meaningful improvement. The calculator displays a trend graph if multiple time points are entered, showing the trajectory of symptom improvement over the course of treatment.
- 7Generate a clinical summary report including total score, severity classification (minimal: 0-10, low: 11-20, moderate: 21-40, high: 41-60, extreme: 61-80), cluster profile, DSM-5 algorithm result, change from baseline (if applicable), and clinical recommendations. The report emphasizes that the PCL-5 is a screening instrument and that a positive screen should be followed by a structured clinical interview (CAPS-5) for definitive diagnosis.
This score of 52 is well above the provisional cutoff and represents high symptom severity. The relatively even distribution across all four clusters suggests a global PTSD presentation. The score of 15 on Cluster E (arousal) indicates significant hypervigilance and sleep disturbance that may require targeted intervention. Referral for comprehensive PTSD evaluation with CAPS-5 is indicated.
A 24-point decrease over 8 weeks of Cognitive Processing Therapy represents excellent treatment response. The score has dropped from above the provisional cutoff (41) to well below it (17), and the DSM-5 algorithm no longer yields a positive screen. This patient has shown clinically meaningful improvement across all symptom clusters. Continued monitoring is recommended to ensure gains are maintained.
A score of 21 falls below the provisional diagnostic cutoff but is clinically significant. The elevated Cluster D score (negative cognitions/mood) suggests this individual may benefit from cognitive interventions targeting trauma-related beliefs even without a full PTSD diagnosis. Many individuals with subthreshold PTSD experience significant functional impairment and respond well to evidence-based treatment.
VA Medical Centers administer the PCL-5 to all veterans at intake and every 2 to 4 weeks during PTSD treatment (Cognitive Processing Therapy or Prolonged Exposure). A clinician tracking a veteran's score from 55 at intake to 22 at session 12 can document clinically meaningful improvement, supporting treatment continuation or transition to maintenance. The 33-point drop exceeds the 10-point clinically meaningful threshold by a wide margin.
Emergency departments and trauma centers use the PCL-5 at 30-day follow-up after acute traumatic events (motor vehicle accidents, assaults, natural disasters) to identify individuals developing acute PTSD symptoms who would benefit from early intervention. Research shows that early identification and treatment within 3 months of trauma exposure produces the best outcomes.
Researchers conducting clinical trials for PTSD treatments use the PCL-5 as a primary or secondary outcome measure because of its strong psychometric properties and widespread acceptance. The instrument free availability and public domain status make it practical for multi-site studies. Change in PCL-5 total score is the most commonly reported outcome in PTSD treatment research published since 2013.
Forensic psychologists administer the PCL-5 as part of comprehensive PTSD evaluations in legal contexts including disability claims, personal injury litigation, criminal defense (PTSD as mitigating factor), and immigration asylum cases. The instrument standardized scoring and well-established psychometric properties make it defensible in legal proceedings, though forensic evaluators must also assess for symptom exaggeration using validity measures.
In military and veteran populations, the PCL-5 should be administered with
In military and veteran populations, the PCL-5 should be administered with awareness that service members may underreport symptoms due to stigma, fear of career impact, or unit cohesion pressure. Supplementing self-report with collateral information from family members or unit leaders can improve detection accuracy. The VA PTSD screening protocol uses the PC-PTSD-5 (a brief 5-item screener) for initial screening, followed by the full PCL-5 for positive screens.
For patients with complex PTSD (resulting from prolonged, repeated trauma such
For patients with complex PTSD (resulting from prolonged, repeated trauma such as childhood abuse or captivity), the PCL-5 may not fully capture the additional symptoms of affect dysregulation, negative self-concept, and disturbances in relationships that characterize complex PTSD. The International Trauma Questionnaire (ITQ) is recommended for complex PTSD assessment.
The PCL-5 has been translated into over 30 languages with validated
The PCL-5 has been translated into over 30 languages with validated translations available for Spanish, Chinese, Arabic, French, German, and many others. When using translated versions, apply cutoff scores validated for the specific cultural and linguistic population rather than the English-language cutoffs, as symptom expression and endorsement patterns vary across cultures.
| Score Range | Severity Level | Clinical Interpretation | Recommended Action |
|---|---|---|---|
| 0-10 | Minimal | Few or no PTSD symptoms reported | No immediate clinical action needed |
| 11-20 | Low | Some symptoms present, below clinical threshold | Monitor, provide psychoeducation |
| 21-32 | Moderate | Clinically significant symptoms, subthreshold | Consider treatment, reassess in 2-4 weeks |
| 33-50 | Moderately High | Probable PTSD, above provisional cutoff | Diagnostic evaluation with CAPS-5, initiate treatment |
| 51-70 | High | Severe PTSD symptom burden | Urgent treatment referral, assess safety |
| 71-80 | Extreme | Maximum symptom severity on all items | Immediate intervention, assess for comorbidity and safety |
What PCL-5 score indicates PTSD?
A total score of 31 to 33 or above suggests probable PTSD. However, a formal diagnosis requires a structured clinical interview (CAPS-5). The cutoff of 33 correctly identifies approximately 88 percent of individuals with PTSD (sensitivity) but also flags approximately 31 percent of individuals without PTSD (1 - specificity). For clinical purposes, any score above 28 warrants further evaluation.
How often should the PCL-5 be administered?
In active PTSD treatment, the PCL-5 is typically administered at intake and every 2 to 4 weeks to track progress. For monitoring remission, administration at 3, 6, and 12 months post-treatment is recommended. A change of 5 points represents reliable change, and 10 to 20 points indicates clinically meaningful improvement. More frequent administration (weekly) may cause test fatigue and is generally unnecessary.
Is the PCL-5 free to use?
Yes. The PCL-5 is in the public domain and freely available from the National Center for PTSD website. No permission, licensing fees, or publisher authorization is required for clinical or research use. The instrument and scoring instructions can be downloaded directly from ptsd.va.gov.
Can the PCL-5 detect malingering?
The PCL-5 does not contain validity scales to detect symptom exaggeration or malingering. In forensic or disability evaluation contexts, the PCL-5 should be supplemented with validity measures such as the Miller Forensic Assessment of Symptoms Test (M-FAST), the Structured Inventory of Malingered Symptomatology (SIMS), or performance validity tests. Unusually high scores (70+) without corresponding functional impairment may warrant closer scrutiny.
What is the difference between PCL-5 and CAPS-5?
The PCL-5 is a 20-item self-report questionnaire that takes 5-10 minutes and serves as a screening tool. The CAPS-5 is a 30-item structured clinical interview administered by a trained clinician that takes 45-60 minutes and serves as the diagnostic gold standard. The PCL-5 is used for screening and treatment monitoring, while the CAPS-5 is used for definitive diagnosis, treatment outcome assessment in research, and forensic evaluation.
Does the PCL-5 work for children and adolescents?
The PCL-5 was developed and validated for adults aged 18 and older. For children and adolescents, the UCLA PTSD Reaction Index for DSM-5 or the Child PTSD Symptom Scale (CPSS-5) are recommended alternatives. These instruments use age-appropriate language and account for developmental differences in PTSD symptom expression.
How does the PCL-5 differ from the PCL for DSM-IV?
The PCL-5 was restructured to align with the DSM-5 four-cluster model (B, C, D, E) replacing the DSM-IV three-cluster model (B, C, D). The PCL-5 includes three new items reflecting DSM-5 additions (blame, negative emotions, reckless behavior), removed one DSM-IV item (foreshortened future), and revised several item wordings. Scores from the PCL (DSM-IV version) and PCL-5 are not directly comparable and should not be used interchangeably.
Consejo Pro
When using the PCL-5 for treatment monitoring, graph the total score over time to visualize the trajectory. Most evidence-based PTSD treatments (CPT, PE, EMDR) produce the steepest symptom decline in sessions 4 through 8. If the score has not decreased by at least 5 points (reliable change) by session 6, discuss the trajectory with the patient and consider treatment adjustments. A flat or increasing trajectory after 8 sessions may indicate the need for a different therapeutic approach.
¿Sabías que?
The PCL-5 is administered millions of times per year worldwide, making it the single most widely used PTSD assessment instrument in history. The National Center for PTSD, which developed and maintains the instrument, reports that the PCL-5 webpage receives over 500,000 downloads annually. Its public domain status and zero cost have made it the standard PTSD screener in VA clinics, military health systems, academic research, and humanitarian organizations operating in conflict zones.